Menu
Recruiting NCT07693283

Expression of Target in Endometriotic Lesions

— Observational Endometriosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Retrospective molecular expression analysis in endometriosis tissue specimens.
Who it may be relevant to
Registry conditions: Endometriosis. Basic parameters: 18 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

To Investigate the Expression of Target in Endometriotic Lesions

Overview

Endometriosis is a common gynecological disorder associated with chronic pelvic pain and infertility, which affects women of reproductive age worldwide. This study aims to investigate the expression patterns of specific molecules in tissue specimens obtained from patients with endometriosis. The investigators will compare the expression levels of these molecules between endometriotic lesions and normal tissue. The primary objective of this study is to elucidate the potential roles of these molecules in the pathogenesis of endometriosis.

Interventions

  • Other Retrospective molecular expression analysis in endometriosis tissue specimens
    This study involves no prospective interventional measures for participants.

Primary outcome measures

  • Expression levels of molecular in endometriotic lesions and adjacent normal tissue [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • Pathologically confirmed endometriosis via laparoscopy and histopathological examination
  • Complete clinical and pathological data available

Exclusion criteria

  • History of any malignant tumor

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

China · 1 center
  • Beijing Tsinghua Changgung Hospital — Beijing

Identifiers

NCT: NCT07693283 · 26154-4-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗